Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational Accepts healthy volunteers

Impairments That Affect Correct Inhaler Use in COPD

ClinicalTrials.gov ID: NCT06135324

Public ClinicalTrials.gov record NCT06135324. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 28, 2026, 4:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prevalence of Impairments in Cognitive Function and Manual Dexterity in Out-patients With COPD and Associations With Correct Inhaler Techniques (INHALE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

INHALE is a one-year, multi-site observational research study funded by Viatris, with two aims: 1. Determine the prevalence of both cognitive impairment and impaired manual dexterity in stable out-patients with chronic obstructive pulmonary disease (COPD). 2. Assess the relationship of cognitive impairment and impaired manual dexterity with patient errors using current pMDIs, SMIs and/or DPIs.

Study identification

NCT ID
NCT06135324
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
COPD Foundation
Other
Enrollment
500 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
60 Years to 90 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 13, 2023
Primary completion
Apr 29, 2025
Completion
Oct 30, 2025
Last update posted
May 10, 2025

2023 – 2025

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
University of Alabama at Birmingham - Lung Health Center Birmingham Alabama 35233 —
RUSH University Chicago Illinois 60612 —
Lahey Clinic, Inc. Burlington Massachusetts 01805 —
Midwest Chest Consultants, PC Saint Charles Missouri 63301 —
Valley Regional Hospital Claremont New Hampshire 03743 —
Atrium Health Wake Forest Baptist Winston-Salem North Carolina 27157 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Erlanger Health Chattanooga Tennessee 37403 —
University of Texas Medical Brach at Galveston Galveston Texas 77555 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06135324, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2025 · Synced Sep 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06135324 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →